• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分光光度法与制药过程分析技术/实时放行检测:从研发到产品生命周期的实际挑战与监管环境

Spectrophotometry and pharmaceutical PAT/RTRT: Practical challenges and regulatory landscape from development to product lifecycle.

作者信息

Panzitta Michele, Calamassi Niccolò, Sabatini Cristina, Grassi Marzia, Spagnoli Chiara, Vizzini Vittoria, Ricchiuto Elisa, Venturini Andrea, Brogi Andrea, Brassier Font Judit, Pontello Lino, Bruno Giorgio, Minghetti Paola, Ricci Maurizio

机构信息

A. Menarini M.L.&S, Via R. Pilo 4, 50131 Firenze, Italy; AFI, Study Group on Product Lifecycle and Process Innovation, viale Ranzoni, 1 20041 Milano.

Department of Pharmaceutical Sciences, Università degli Studi di Perugia, via del Liceo 1, 06123 Perugia, Italy; AFI, Study Group on Product Lifecycle and Process Innovation, viale Ranzoni, 1 20041 Milano.

出版信息

Int J Pharm. 2021 May 15;601:120551. doi: 10.1016/j.ijpharm.2021.120551. Epub 2021 Apr 6.

DOI:10.1016/j.ijpharm.2021.120551
PMID:33831483
Abstract

European Pharmacopoeia includes dedicated chapters for Raman, NIR and Chemometrics, as well as there is a lot of Academia research on the matter. Despite that, the word innovation is often associated to such tools and there is a still slow implementation at industry. The paper is the outcome of the Associazione Farmaceutici dell'Industria (AFI) Study Group on Process Innovation and Product Lifecycle; the aim is to describe some case studies referring to practical approaches in pharmaceutical industry, in order to depict challenges and opportunities for the implementation of spectroscopic techniques. Case studies include: feasibility and pre-screening evaluations, chemometric model development approaches, way for the method maintenance during commercial manufacturing, challenges for implementation on existing equipment and on sterile processes. Case studies refer to oral solid products, liquid products and sterile Active Pharmaceutical Ingradient (API) manufacturing. There are already successful and robust spectroscopic applications in pharmaceutical industry and the technology is mature: this is the outcome of a strong applied research performed at pharmaceutical production departments. It is necessary to acknowledge efforts done by industry as Research for strengthening the cooperation with Academia, so that advantage of process innovation might reach the patients in a fastest way.

摘要

《欧洲药典》设有拉曼光谱、近红外光谱和化学计量学的专门章节,并且学术界也有大量关于此方面的研究。尽管如此,创新一词常与这些工具相关联,但其在行业中的实施仍较为缓慢。本文是制药工业协会(AFI)工艺创新与产品生命周期研究小组的成果;目的是描述一些制药行业实际应用方法的案例研究,以阐述实施光谱技术的挑战与机遇。案例研究包括:可行性和预筛选评估、化学计量学模型开发方法、商业化生产期间方法维护的方式、在现有设备和无菌工艺上实施的挑战。案例研究涉及口服固体产品、液体产品和无菌活性药物成分(API)生产。制药行业已经有成功且可靠的光谱应用,并且该技术已经成熟:这是制药生产部门进行大量应用研究的成果。有必要认可行业为加强与学术界合作所做的努力,以便工艺创新的优势能够以最快的方式惠及患者。

相似文献

1
Spectrophotometry and pharmaceutical PAT/RTRT: Practical challenges and regulatory landscape from development to product lifecycle.分光光度法与制药过程分析技术/实时放行检测:从研发到产品生命周期的实际挑战与监管环境
Int J Pharm. 2021 May 15;601:120551. doi: 10.1016/j.ijpharm.2021.120551. Epub 2021 Apr 6.
2
Why should the pharmaceutical industry claim for the implementation of second-order chemometric models-A critical review.制药行业为何主张实施二阶化学计量学模型——批判性回顾。
J Pharm Biomed Anal. 2020 Feb 5;179:112965. doi: 10.1016/j.jpba.2019.112965. Epub 2019 Nov 4.
3
Process Analytical Technology for Crystallization of Active Pharmaceutical Ingredients.原料药结晶过程分析技术。
Curr Pharm Des. 2018;24(21):2456-2472. doi: 10.2174/1381612824666180629111632.
4
Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.实现连续制造:药物合成、后处理及分离的技术与方法。2014年5月20 - 21日连续制造研讨会
J Pharm Sci. 2015 Mar;104(3):781-91. doi: 10.1002/jps.24252. Epub 2014 Dec 2.
5
Quality by design and process analytical technology for sterile products--where are we now?质量源于设计和无菌产品的过程分析技术——我们现在在哪里?
AAPS PharmSciTech. 2011 Mar;12(1):114-8. doi: 10.1208/s12249-010-9566-x. Epub 2010 Dec 23.
6
Opportunities and challenges of real-time release testing in biopharmaceutical manufacturing.生物制药生产中实时放行检测的机遇与挑战。
Biotechnol Bioeng. 2017 Nov;114(11):2445-2456. doi: 10.1002/bit.26383. Epub 2017 Aug 29.
7
Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.连续制药生产中的控制系统工程。2014年5月20 - 21日,连续制造研讨会
J Pharm Sci. 2015 Mar;104(3):832-9. doi: 10.1002/jps.24311. Epub 2014 Dec 26.
8
Process analytical technologies and injectable drug products: Is there a future?过程分析技术与注射剂药品:未来可期?
Int J Pharm. 2019 Jan 10;554:21-35. doi: 10.1016/j.ijpharm.2018.10.070. Epub 2018 Oct 30.
9
Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.设备与分析公司面临持续挑战。2014年5月20 - 21日 连续制造研讨会
J Pharm Sci. 2015 Mar;104(3):821-31. doi: 10.1002/jps.24282. Epub 2014 Dec 1.
10
A Process Analytical Technology (PAT) approach to control a new API manufacturing process: development, validation and implementation.采用过程分析技术(PAT)控制新型原料药生产工艺:开发、验证和实施。
Talanta. 2014 Mar;120:114-25. doi: 10.1016/j.talanta.2013.11.072. Epub 2013 Dec 2.

引用本文的文献

1
Comparative Investigation of the Spectroscopic Behavior Based on High-Concentrated Solution in Nitrogen and Air Atmospheres.基于高浓度溶液在氮气和空气气氛中的光谱行为的比较研究。
Int J Mol Sci. 2023 Aug 10;24(16):12629. doi: 10.3390/ijms241612629.
2
Challenges and Opportunities of Implementing Data Fusion in Process Analytical Technology-A Review.实施数据融合在过程分析技术中的挑战与机遇——综述
Molecules. 2022 Jul 28;27(15):4846. doi: 10.3390/molecules27154846.
3
Process Analytical Technology Tools for Monitoring Pharmaceutical Unit Operations: A Control Strategy for Continuous Process Verification.
用于监测制药单元操作的过程分析技术工具:连续工艺验证的控制策略
Pharmaceutics. 2021 Jun 21;13(6):919. doi: 10.3390/pharmaceutics13060919.